Methods and trials of treatment of subjects with removal, mutation or reduced expression of SHANK3

摘要

Insulin-like growth factor 1 (IGF-1) or an active IGF-1 fragment, such as tripeptide (1-3) IGF-1, for use in the treatment of Phelan-McDermid syndrome.